Evidence map›Paper›PMID 38932227›Full record

ArticleViruses2024

Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems.

Jonathan Burnie, Claire Fernandes, Ayushi Patel, Arvin Tejnarine Persaud, Deepa Chaphekar, Danlan Wei, Timothy Kit Hin Lee, Vera A Tang, Claudia Cicala, James Arthos and 1 more

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan BurnieDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.ORCID 0000-0003-0980-9255
Claire FernandesDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.
Ayushi PatelDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.
Arvin Tejnarine PersaudDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.ORCID 0000-0003-4874-8969
Deepa ChaphekarDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.
Danlan WeiLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Timothy Kit Hin LeeDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.
Vera A TangFlow Cytometry and Virometry Core Facility, Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Claudia CicalaLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
James ArthosLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-6767-4267
Christina GuzzoDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada.

Funding

Interaction of HIV envelope with cell surface receptorsZIAAI000883 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ARTHOS, JAMES L · 2009 to 2024
$14.0M
6 · The paper itself

Abstract

The HIV envelope glycoprotein (Env) is a trimeric protein that facilitates viral binding and fusion with target cells. As the sole viral protein on the HIV surface, Env is important both for immune responses to HIV and in vaccine designs. Targeting Env in clinical applications is challenging due to its heavy glycosylation, high genetic variability, conformational camouflage, and its low abundance on virions. Thus, there is a critical need to better understand this protein. Flow virometry (FV) is a useful methodology for phenotyping the virion surface in a high-throughput, single virion manner. To demonstrate the utility of FV to characterize Env, we stained HIV virions with a panel of 85 monoclonal antibodies targeting different regions of Env. A broad range of antibodies yielded robust staining of Env, with V3 antibodies showing the highest quantitative staining. A subset of antibodies tested in parallel on viruses produced in CD4

Indexed as

env Gene Products, Human Immunodeficiency VirusHIV-1VirionAntibodies, MonoclonalCD4-Positive T-LymphocytesHEK293 CellsHIV AntibodiesHIV InfectionsHumansAntibodies, Monoclonalenv Gene Products, Human Immunodeficiency VirusHIV Antibodiescalibrated flow virometryEnv conformationgp120/gp41HIV EnvHIV trimerhuman immunodeficiency virus (HIV)molecules of equivalent soluble fluorophore (MESF)nanoscale flow cytometryneutralizationvirion capture

Identifiers

PMID38932227
PMCPMC11209363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.